WINTON GROUP Ltd Boosts Stake in Healthpeak Properties, Inc. $DOC

WINTON GROUP Ltd increased its position in Healthpeak Properties, Inc. (NYSE:DOC) by 568.3% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 133,210 shares of the real estate investment trust’s stock after purchasing an additional 113,276 shares during the period. WINTON GROUP Ltd’s holdings in Healthpeak Properties were worth $2,142,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also made changes to their positions in the company. Fiduciary Trust Co lifted its holdings in shares of Healthpeak Properties by 4.9% in the 3rd quarter. Fiduciary Trust Co now owns 13,807 shares of the real estate investment trust’s stock valued at $264,000 after purchasing an additional 644 shares during the last quarter. Patton Fund Management Inc. grew its position in Healthpeak Properties by 5.2% during the 4th quarter. Patton Fund Management Inc. now owns 13,002 shares of the real estate investment trust’s stock worth $209,000 after purchasing an additional 648 shares during the last quarter. Quadrant Capital Group LLC increased its stake in Healthpeak Properties by 1.9% in the third quarter. Quadrant Capital Group LLC now owns 37,650 shares of the real estate investment trust’s stock valued at $721,000 after purchasing an additional 718 shares during the period. New Mexico Educational Retirement Board increased its stake in Healthpeak Properties by 2.5% in the fourth quarter. New Mexico Educational Retirement Board now owns 32,200 shares of the real estate investment trust’s stock valued at $518,000 after purchasing an additional 800 shares during the period. Finally, Arjuna Capital increased its stake in Healthpeak Properties by 5.7% in the fourth quarter. Arjuna Capital now owns 15,606 shares of the real estate investment trust’s stock valued at $251,000 after purchasing an additional 838 shares during the period. 93.57% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of research analysts have commented on DOC shares. Morgan Stanley lifted their price objective on shares of Healthpeak Properties from $18.00 to $20.00 and gave the company an “overweight” rating in a research note on Friday, May 22nd. Scotiabank lifted their price objective on shares of Healthpeak Properties from $19.00 to $21.00 and gave the company a “sector perform” rating in a research note on Wednesday, May 27th. UBS Group lifted their price objective on shares of Healthpeak Properties from $17.00 to $19.00 and gave the company a “neutral” rating in a research note on Wednesday, May 13th. Wall Street Zen upgraded shares of Healthpeak Properties from a “sell” rating to a “hold” rating in a research note on Sunday, May 10th. Finally, Citigroup lifted their price objective on shares of Healthpeak Properties from $17.50 to $20.00 and gave the company a “neutral” rating in a research note on Tuesday, May 12th. Four equities research analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, Healthpeak Properties has an average rating of “Hold” and an average target price of $19.38.

Insider Buying and Selling at Healthpeak Properties

In other news, insider Scott R. Bohn sold 10,989 shares of Healthpeak Properties stock in a transaction dated Tuesday, May 12th. The shares were sold at an average price of $19.45, for a total value of $213,736.05. Following the sale, the insider owned 7,636 shares of the company’s stock, valued at $148,520.20. The trade was a 59.00% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.23% of the stock is currently owned by insiders.

Healthpeak Properties Stock Up 0.0%

Shares of NYSE:DOC opened at $19.80 on Monday. The company has a market cap of $13.65 billion, a price-to-earnings ratio of 61.87, a PEG ratio of 3.09 and a beta of 1.05. The firm’s 50-day simple moving average is $17.96 and its 200-day simple moving average is $17.39. The company has a quick ratio of 2.96, a current ratio of 2.96 and a debt-to-equity ratio of 1.15. Healthpeak Properties, Inc. has a fifty-two week low of $15.70 and a fifty-two week high of $20.27.

Healthpeak Properties (NYSE:DOC) last issued its earnings results on Tuesday, May 5th. The real estate investment trust reported $0.45 earnings per share for the quarter, beating the consensus estimate of $0.43 by $0.02. The business had revenue of $752.95 million for the quarter, compared to the consensus estimate of $694.59 million. Healthpeak Properties had a net margin of 7.73% and a return on equity of 2.61%. The business’s quarterly revenue was up 7.1% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.46 earnings per share. Healthpeak Properties has set its FY 2026 guidance at 1.710-1.750 EPS. As a group, equities research analysts predict that Healthpeak Properties, Inc. will post 1.74 earnings per share for the current year.

Healthpeak Properties Announces Dividend

The company also recently announced a monthly dividend, which will be paid on Friday, June 26th. Stockholders of record on Monday, June 15th will be issued a $0.1017 dividend. The ex-dividend date of this dividend is Monday, June 15th. This represents a c) annualized dividend and a dividend yield of 6.2%. Healthpeak Properties’s payout ratio is presently 381.25%.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.